Recent studies indicate that c-di-GMP increases the expression MIG/CXCL9 (a chemoattractant for activated T cells), suggesting possible antitumor activity and inhibiting basal and growth factor-induced proliferation of human colon carcinoma cells (8, 9). This evidence concerns the gene CXCL9 and colon carcinoma.